期刊文献+

75岁及以上老年急性失代偿心力衰竭患者死亡原因分析 被引量:8

Analysis of the causes of death in elderly patients with acute decompensated heart failure aged 75 years and over
原文传递
导出
摘要 目的探讨75岁及以上急性心衰患者的临床特点及死亡原因。方法试验设计属于前瞻性随访研究,以2012年1月至-2014年12月期间符合条件的急性心衰患者为研究对象。根据年龄分为年龄≥75岁组和年龄〈75岁组,记录患者的一般临床资料。随访以电话随访为主,辅以住院随访、门诊随访。生存率估算应用Kaplan—Meier法,组间生存率曲线差异采用Logrank检验,应用多变量Cox比例风险回归分析死亡的独立危险因素。结果与年龄〈75岁组相比,年龄≥75岁组缺血性心脏病、高血压病、陈旧性心肌梗死比例较高,男性、糖尿病比例和体质指数(BMI)较低。年龄较高组左心室射血分数(LVEF)水平较高,总胆固醇、三酰甘油、低密度脂蛋白胆固醇(LDL-C)水平较低。KaplanMeier曲线表明,年龄≥75岁组全因死亡率(χ^2=4.005,P=0.045)、非心血管死亡率(χ^2=4.418,P=0.041)显著高于年龄〈75岁组,而心血管病死亡率无显著差异(χ^2=0.754,P=0.385)。在非心血管死亡的患者中,年龄≥75岁组死于肺部感染者12例(63.2%),年龄〈75岁组死于肺部感染者3例(25.0%),2组之间有统计学意义(χ^2=4.288,P=0.038)。多变量Cox比例风险回归分析显示年龄≥75岁是预测急性心衰患者全死因[HR(95%CI):1.75(1.28~3.13),Waldχ^2=2.914,P=0.026]和非心血管死亡[HR(95%CI):2.71(1.50~6.55),Waldχ^2=2.266,P=0.0383的独立危险因素。结论年龄≥75岁是影响急性心衰患者全死因和非心血管病死亡的独立危险因素,但是并非影响心血管病死亡的独立危险因素,这对于建立更合理的老年心衰治疗策略具有一定的指导意义。 Objective To explore the clinical characteristics and causes of death in patients with acute heart failure at aged 75 and over. Methods The prospective study collected 175 patients with aeute heart failure from January 2012 to December 2014. They were divided into ≥75 years old group and〈75 years old group and the general clinical data were recorded. Follow-up was performed mainly by telephone with supplemented hospitalization follow-up and outpatient follow-up. Survival rates were assessed by Kaplan-Meier method. The survival rate difference between the two groups was compared using the log-rank test. Multivariate Cox proportional hazards regression analysis was used to determine the independent risk factors for death. Results The proportions of ischemic heart disease, hypertension and old myocardial infarction were higher in the elderly group than in the young group with a higher proportion of male, diabetes and body mass index in 〈75 years old group. Elderly group had a higher level of left ventricular ejection fraction(LVEF)and a lower level of total cholesterol, triglycerides and low density lipoprotein cholesterol(LDL-C). Kaplan-Meier curves showed that all- cause mortality(χ^2 = 4. 005,P= 0. 045) and non cardiovascular mortality(χ^2= 4. 418,P= 0. 041) were significantly higher in the elderly group than in the younger group, whereas cardiovascular mortality had no significant difference between the two groups (χ^2 = 0. 754, P = 0. 385 ). In patients with non cardiovascular mortality, 12 cases (63.2%)died of pulmonary infection in elderly group, 3 cases (25.0%) died of lung infection in younger group, and the difference was statistically significant between the 2 groups (χ^2 = 4. 288, P = 0. 038) . Multivariate Cox proportional hazards regression analysis showed that age≥75 years was an independent predictor for both non-cardiovascular mortality [HR(95%CI) :2.71(1.50-6.55) ,Wald χ^2 =2. 266,P=0. 038land all-cause mortality[HR(95GCI):1.75 ( 1.28-3.13), Waldχ^2 = 2.914, P =0. 026 ] in patients with acute heart failure. Conclusions Age ≥75 years is an independent risk factor for all dead patients with acute heart failure and non- cardiovascular death,but it is not the independent risk factors for cardiovascular death, which is of great significance to establish a more rational treatment strategy for senile heart failure.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2017年第6期650-654,共5页 Chinese Journal of Geriatrics
基金 河南省科技发展计划(17210241001) 河南省医学科技攻关计划(201602262)
关键词 急性失代偿心力衰竭 危险因素 预后 Acute decompensated heart failure Risk factors Prognosis
  • 相关文献

参考文献5

二级参考文献79

  • 1曹雅旻,胡大一,吴彦,王宏宇.我国基层医院慢性心力衰竭主要原因的初步调查[J].中华内科杂志,2005,44(7):487-489. 被引量:29
  • 2谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 4中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 5Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 6Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 7Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 8Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 9Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 10Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.

共引文献1156

同被引文献84

引证文献8

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部